lung cancer

Takeda gets a win for its Wave1 pipeline, as Exkivity nabs FDA approval
Pharmaforum
Thu, 09/16/21 - 10:44 am
Takeda
FDA
lung cancer
Exkivity
World Lung 2021 – front-line competition lines up behind Keytruda
EP Vantage
Tue, 09/14/21 - 10:43 am
World Lung
Merck
Keytruda
CStone Pharmaceuticals
Shanghai Junshi Biosciences
lung cancer
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Motley Fool
Fri, 08/27/21 - 10:54 am
CureVac
Boehringer Ingelheim
MRNA
lung cancer
vaccines
Moderna Therapeutics
BioNTech
J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech
Pharmaforum
Thu, 08/26/21 - 08:42 pm
JNJ
Optellum
digital biomarker
lung cancer
artificial intelligence
Regeneron drug extends survival in lung cancer trial, lifting company's hopes in field
BioPharma Dive
Thu, 08/5/21 - 11:02 pm
Regeneron
Sanofi
Libtayo
clinical trials
lung cancer
Merck KGaA’s targeted lung cancer drug tepotinib wins early access in UK
Pharmaforum
Thu, 07/15/21 - 12:29 pm
Merck KGaA
lung cancer
UK
tepotinib
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Takeda fleshes out case for oral EGFR drug with follow-up pivotal data in non-small cell lung cancer
Endpoints
Wed, 05/19/21 - 11:14 pm
ASCO 2021
lung cancer
Takeda
FDA
non-small cell lung cancer
Nuvalent bags $135M to trial resistance-beating kinase inhibitors in lung cancer
Fierce Biotech
Tue, 05/11/21 - 11:05 am
Nuvalent
funding
lung cancer
Takeda earns win for its TKI inhibitor in tiny lung cancer group — but GI side effects could be an early red flag
Endpoints
Thu, 01/28/21 - 10:41 am
Takeda
lung cancer
mobocertinib
non-small cell lung cancer
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Bloomberg
Sun, 10/25/20 - 11:30 pm
Mirati Therapeutics
Amgen
adagrasib
lung cancer
Flame Biosciences to Ignite Pipeline with $100M Common Stock Financing
BioSpace
Thu, 10/1/20 - 11:15 pm
Flame Biosciences
lung cancer
BridgeBio's Navire preps SHP2 blocker for lung cancer trial after positive mouse study
Fierce Biotech
Mon, 09/14/20 - 10:14 am
Bridge Bio
Navire Pharma
lung cancer
clinical trials
IACS-13909
FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug
Pharmaforum
Wed, 08/26/20 - 11:03 am
Merck KGaA
MET inhibitors
tepotinib
lung cancer
Teva Pharmaceuticals Unit Actavis Generics Wins FDA Approval for Lung Cancer Drug Pemetrexed
Motley Fool
Tue, 08/25/20 - 12:06 am
generics
Teva Pharmaceutical
Actavis
lung cancer
Pemetrexed
chemotherapy
Alimta
AZ aims to cut cancer clinic visits with new Imfinzi regimen
Pharmaforum
Tue, 08/18/20 - 10:58 am
AstraZeneca
lung cancer
bladder cancer
Imfinizi
dosing
Deaths from the most common lung cancer are falling fast, hinting at the impact of improved treatment
Stat
Wed, 08/12/20 - 11:51 pm
lung cancer
non-small cell lung cancer
targeted therapeutics
Bristol Myers' Opdivo-Yervoy duo slashes mesothelioma death risk by 26%
Fierce Pharma
Sat, 08/8/20 - 10:46 pm
WCLC
lung cancer
mesothelioma
Bristol-Myers Squibb
Opdivo
Yervoy
clinical trials
Pfizer's Lorbrena makes play for earlier lung cancer use with Xalkori-topping data
Fierce Pharma
Wed, 08/5/20 - 11:22 pm
Pfizer
Lorbrena
lung cancer
Xalkori
clinical trials
A turn-up for Spectrum’s book
EP Vantage
Tue, 07/28/20 - 10:32 am
poziotinib
Spectrum Pharmaceuticals
lung cancer
Takeda

Pages